• BSTEAD, as a conglomerate, appears undervalued on a sum-of-parts basis. The aggregate of its share of market cap in the listed subsidiaries and associate – namely Pharmaniaga (56% stake), Boustead Plantations (57% stake), BHIC (65% stake) and Affin Bank (21% stake) – works out to be RM2.03bn currently, which easily surpasses BSTEAD existing market cap of RM1.35bn. This has yet to take into consideration the valuations of its unlisted property assets (including valuable land bank). • BSTEAD is also an indirect proxy to the Covid-19 vaccine thematic play and rising CPO prices, which have lifted the share prices of Pharmaniaga (up 94% since mid-July) and Boustead Plantations (+38% since end-August), respectively. • Meanwhile, its major shareholder LTAT (which holds a 59.4% stake) could be deciding on whether to proceed with the preliminary proposal to take BSTEAD private – at an indicative price of RM0.80 per share – by 27 October 2020. • From a trough of RM0.345 in March, BSTEAD’s share price has plotted higher highs and higher lows to reach a peak of RM0.825 in July before entering a consolidation mode thereafter. • On the chart, the stock has rebounded from the lower trendline recently to end at RM0.665 yesterday, suggesting that a probable continuation of the upward momentum. • This is supported by the current share price that is still trending above its 50-day simple moving average. • Riding on the ascending price channel, BSTEAD shares could climb towards our resistance thresholds of RM0.76 (R1) and RM0.85 (R2), which represents upside potentials of 14% and 28%, respectively. • Our stop loss level is pegged at RM0.59 (or 11% downside risk). Our stop loss level is set at RM0.49 (8% downside risk from yesterday’s closing price of RM0.535). This document has been prepared for general circulation based on information obtained from sources believed to be reliable but we do not make any representations as to its accuracy or completeness. Any recommendation contained in this document does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may read this document. This document is for the information of addressees only and is not to be taken in substitution for the exercise of judgement by addressees and further shall not be re-distributed to any other third party. Rakuten Trade Sdn Bhd accepts no liability whatsoever for any direct or consequential loss arising from any use of this document or any solicitations of an offer to buy or sell any securities. Rakuten Trade Sdn Bhd and its associates, their directors, and/or employees may have positions in, and may affect transactions in securities mentioned herein from time to time in the open market or otherwise, and may receive brokerage fees or act as principal or agent in dealings with respect to these companies. The Contra Trade account allows clients to buy shares based on available cash and/or collateral shares value after hair cut at a higher multiplier. The multiplier varies according to the type of counters clients intend to buy. Outstanding purchase(s) in the Contra Account need to be paid and/or settled within 2 (two) trading days after the transaction date (T), failing which it will be force-sold on T+2. Published:
RAKUTEN TRADE SDN BHD
Registration No: 199301011963 (266701-P) Kenny Yee Shen Pin Level 7, Kenanga Tower, 237, Jalan Tun Razak, 50400 Kuala Lumpur, Malaysia Head of Research